London Daily

Focus on the big picture.
Wednesday, Jan 28, 2026

Pandemic-hit NHS wastes over £560mn yearly on ‘unnecessary’ & addictive pills with severe withdrawal symptoms – study

Pandemic-hit NHS wastes over £560mn yearly on ‘unnecessary’ & addictive pills with severe withdrawal symptoms – study

Despite the Covid pandemic, the NHS is reportedly wasting as much as £568 million yearly on habit-forming drugs like painkillers and sleeping pills that the majority of patients do not need, leading to dangerous addictions.

Doctors in England are unnecessarily pushing dependency-causing opioids, antidepressants and other pills, according to a new study by the Council for Evidence-based Psychiatry (CEP). Researchers found that three in four prescriptions were totally unnecessary in some cases.

The study, published on Tuesday in the journal Addictive Behaviours, revealed that, for many patients, their symptoms were not severe enough to warrant such medication. In other cases, safer options of treatment, such as counselling or less toxic drugs, were not fully explored while there were also instances of patients who were put on the pills for longer than required.

“Money is being wasted at a time when the health service is strapped for cash. The NHS is not taking this problem seriously and many doctors don’t appreciate the extent to which withdrawal from these medicines is a problem,” Dr James Davies, the study’s co-lead author, told the Daily Mail.


Between 2015 and 2018, the study estimated, there was a taxpayer bill of £1.7 billion for prescriptions for antidepressants, opioids, gabapentinoids, benzodiazepines and Z-drugs (sleeping pills). The total costs accounted for the price of the drugs, the average consultation cost (about £33) of seeing a General Practitioner (GP), and dispensing fees.

NHS figures reportedly show that nearly 17 million people a year in the country are getting a prescription for such drugs. The level of waste is so colossal that it could go towards paying the salaries of another 10,000 GPs or 20,000 nurses, according to the Daily Mail, which reported that the Department of Health and Social Care is yet to finalise plans to tackle the issue.

Nearly half the taxpayer money being wasted each year – to the tune of £288 million – goes towards highly addictive opioid painkillers followed by £158 million a year for gabapentinoids. But the researchers, from Roehampton University, Greenwich University and University College London, warn that it is likely the total amount lost is far higher than the “conservative” estimates in the study.

In addition, the study does not account for the significant costs related to harms caused by habit-forming drugs. These include higher disability payments and lost tax revenues, as well as workplace absenteeism and decreased productivity.

Besides the financial losses, unnecessary prescription also exacts a human cost: when people try to kick the habit, they suffer severe withdrawal symptoms, including stomach cramps, blurred vision and loss of appetite. For instance, studies on benzodiazepine usage reportedly show that 50% of those on the drugs for as little as four weeks suffer anxiety, dizziness, concentration problems, nightmares and weakness. That figure rises to 100% for people taking the medication for over six months.

Commenting on the study, Tory MP Danny Kruger, who chairs the All Party Parliamentary Group for Prescribed Drug Dependence, said that a “fraction of these wasted costs should now be invested in a helpline and dedicated withdrawal support services.”

In 2019, a Public Health England report revealed that “hundreds of thousands” of patients had become dependent on medicines and recommended face-to-face support, better training for doctors on the risks of drug dependency, and a 24-hour helpline on how to reduce medication.

While little action has occurred since, a Department of Health and Social Care spokesman told the Daily Mail that ministers are finally backing plans for a helpline and will be “working closely” with the NHS to implement the recommendations.

Newsletter

Related Articles

0:00
0:00
Close
Starmer Seeks Economic Gains From China Visit While Navigating US Diplomatic Sensitivities
Starmer Says China Visit Will Deliver Economic Benefits as He Prepares to Meet Xi Jinping
UK Prime Minister Starmer Arrives in China to Bolster Trade and Warn Firms of Strategic Opportunities
The AI Hiring Doom Loop — Algorithmic Recruiting Filters Out Top Talent and Rewards Average or Fake Candidates
Amazon to Cut 16,000 Corporate Jobs After Earlier 14,000 Reduction, Citing Streamlining and AI Investment
Federal Reserve Holds Interest Rate at 3.75% as Powell Faces DOJ Criminal Investigation During 2026 Decision
Putin’s Four-Year Ukraine Invasion Cost: Russia’s Mass Casualty Attrition and the Donbas Security-Guarantee Tradeoff
Wall Street Bets on Strong US Growth and Currency Moves as Dollar Slips After Trump Comments
UK Prime Minister Traveled to China Using Temporary Phones and Laptops to Limit Espionage Risks
Google’s $68 Million Voice Assistant Settlement Exposes Incentives That Reward Over-Collection
Kim Kardashian Admits Faking Paparazzi Visit to Britney Spears for Fame in Early 2000s
UPS to Cut 30,000 More Jobs by 2026 Amid Shift to High-Margin Deliveries
France Plans to Replace Teams and Zoom Across Government With Homegrown Visio by 2027
Trump Removes Minneapolis Deportation Operation Commander After Fatal Shooting of Protester
Iran’s Elite Wealth Abroad and Sanctions Leakage: How Offshore Luxury Sustains Regime Resilience
U.S. Central Command Announces Regional Air Exercise as Iran Unveils Drone Carrier Footage
Four Arrested in Andhra Pradesh Over Alleged HIV-Contaminated Injection Attack on Doctor
Hot Drinks, Hidden Particles: How Disposable Cups Quietly Increase Microplastic Exposure
UK Banks Pledge £11 Billion Lending Package to Help Firms Expand Overseas
Suella Braverman Defects to Reform UK, Accusing Conservatives of Betrayal on Core Policies
Melania Trump Documentary Sees Limited Box Office Traction in UK Cinemas
Meta and EssilorLuxottica Ray-Ban Smart Glasses and the Non-Consensual Public Recording Economy
WhatsApp Develops New Meta AI Features to Enhance User Control
Germany Considers Gold Reserves Amidst Rising Tensions with the U.S.
Michael Schumacher Shows Significant Improvement in Health Status
Greenland’s NATO Stress Test: Coercion, Credibility, and the New Arctic Bargaining Game
Diego Garcia and the Chagos Dispute: When Decolonization Collides With Alliance Power
Trump Claims “Total” U.S. Access to Greenland as NATO Weighs Arctic Basing Rights and Deterrence
Air France and KLM Suspend Multiple Middle East Routes as Regional Tensions Disrupt Aviation
U.S. winter storm triggers 13,000-plus flight cancellations and 160,000 power outages
Poland delays euro adoption as Domański cites $1tn economy and zloty advantage
White House: Trump warns Canada of 100% tariff if Carney finalizes China trade deal
PLA opens CMC probe of Zhang Youxia, Liu Zhenli over Xi authority and discipline violations
ICE and DHS immigration raids in Minneapolis: the use-of-force accountability crisis in mass deportation enforcement
UK’s Starmer and Trump Agree on Urgent Need to Bolster Arctic Security
Starmer Breaks Diplomatic Restraint With Firm Rebuke of Trump, Seizing Chance to Advocate for Europe
UK Finance Minister Reeves to Join Starmer on China Visit to Bolster Trade and Economic Ties
Prince Harry Says Sacrifices of NATO Forces in Afghanistan Deserve ‘Respect’ After Trump Remarks
Barron Trump Emerges as Key Remote Witness in UK Assault and Rape Trial
Nigel Farage Attended Davos 2026 Using HP Trust Delegate Pass Linked to Sasan Ghandehari
Gold Jumps More Than 8% in a Week as the Dollar Slides Amid Greenland Tariff Dispute
BlackRock Executive Rick Rieder Emerges as Leading Contender to Succeed Jerome Powell as Fed Chair
Boston Dynamics Atlas humanoid robot and LG CLOiD home robot: the platform lock-in fight to control Physical AI
United States under President Donald Trump completes withdrawal from the World Health Organization: health sovereignty versus global outbreak early-warning access
FBI and U.S. prosecutors vs Ryan Wedding’s transnational cocaine-smuggling network: the fight over witness-killing and cross-border enforcement
Trump Administration’s Iran Military Buildup and Sanctions Campaign Puts Deterrence Credibility on the Line
Apple and OpenAI Chase Screenless AI Wearables as the Post-iPhone Interface Battle Heats Up
Tech Brief: AI Compute, Chips, and Platform Power Moves Driving Today’s Market Narrative
NATO’s Stress Test Under Trump: Alliance Credibility, Burden-Sharing, and the Fight Over Strategic Territory
OpenAI’s Money Problem: Explosive Growth, Even Faster Costs, and a Race to Stay Ahead
×